Healthcare provider profile · identity verified

Michael M Hirsch, MD

Internal Medicine · HICKORY, NC · NPI 1841281623

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	972	250
Amlodipine Besylate	Amlodipine Besylate	844	226
Lisinopril	Lisinopril	468	133
Rosuvastatin Calcium	Rosuvastatin Calcium	450	136
Omeprazole	Omeprazole	431	135
Levothyroxine Sodium	Levothyroxine Sodium	366	94
Losartan Potassium	Losartan Potassium	342	94
Metoprolol Succinate	Metoprolol Succinate	269	68
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	257	73
Tramadol Hcl	Tramadol Hcl	234	52
Eliquis	Apixaban	222	42
Pantoprazole Sodium	Pantoprazole Sodium	209	63
Simvastatin	Simvastatin	196	53
Escitalopram Oxalate	Escitalopram Oxalate	195	53
Metformin Hcl	Metformin Hcl	191	56
Tamsulosin Hcl	Tamsulosin Hcl	172	56
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	164	45
Atenolol	Atenolol	159	42
Gabapentin	Gabapentin	142	46
Meloxicam	Meloxicam	139	44
Fluticasone Propionate	Fluticasone Propionate	129	52
Hydrochlorothiazide	Hydrochlorothiazide	124	36
Potassium Chloride	Potassium Chloride	119	38
Prednisone	Prednisone	117	93
Pravastatin Sodium	Pravastatin Sodium	116	31
Lorazepam	Lorazepam	105	30
Ezetimibe	Ezetimibe	102	29
Furosemide	Furosemide	99	35
Allopurinol	Allopurinol	97	26
Clonazepam	Clonazepam	96	18
Jardiance	Empagliflozin	90	21
Clopidogrel	Clopidogrel Bisulfate	86	23
Hydralazine Hcl	Hydralazine Hcl	86	23
Carvedilol	Carvedilol	83	22
Zolpidem Tartrate	Zolpidem Tartrate	82	24
Doxazosin Mesylate	Doxazosin Mesylate	81	21
Valsartan	Valsartan	80	23
Metoprolol Tartrate	Metoprolol Tartrate	79	23
Montelukast Sodium	Montelukast Sodium	79	24
Citalopram Hbr	Citalopram Hydrobromide	77	21
Alendronate Sodium	Alendronate Sodium	73	25
Azithromycin	Azithromycin	72	63
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	69	17
Celecoxib	Celecoxib	68	26
Famotidine	Famotidine	67	22
Alprazolam	Alprazolam	66	17
Finasteride	Finasteride	66	20
Esomeprazole Magnesium	Esomeprazole Magnesium	65	17
Tresiba Flextouch U-200	Insulin Degludec	64	19
Doxycycline Hyclate	Doxycycline Hyclate	61	45
Trazodone Hcl	Trazodone Hcl	59	17
Sertraline Hcl	Sertraline Hcl	58	15
Diclofenac Sodium	Diclofenac Sodium	56	25
Duloxetine Hcl	Duloxetine Hcl	54	14
Metformin Hcl Er	Metformin Hcl	52	17
Ozempic	Semaglutide	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	51	14
Synthroid	Levothyroxine Sodium	50	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	15
Lovastatin	Lovastatin	49	11
Donepezil Hcl	Donepezil Hcl	48	16
Ipratropium Bromide	Ipratropium Bromide	48	20
Spironolactone	Spironolactone	48	15
Albuterol Sulfate Hfa	Albuterol Sulfate	47	29
Mirtazapine	Mirtazapine	47	14
Diazepam	Diazepam	45	suppressed
Telmisartan	Telmisartan	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	38
Glimepiride	Glimepiride	40	suppressed
Repatha Sureclick	Evolocumab	36	suppressed
Pregabalin	Pregabalin	34	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Azelastine Hcl	Azelastine Hcl	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	26
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	27
Ondansetron Hcl	Ondansetron Hcl	31	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Naproxen	Naproxen	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Vascepa	Icosapent Ethyl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	11
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Testosterone	Testosterone	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Cefdinir	Cefdinir	13	13
Cephalexin	Cephalexin	13	12
Digoxin	Digoxin	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Torsemide	Torsemide	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Insulin Degludec	Insulin Degludec	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error